STAT3 silencing enhances the efficacy of the HSV.tk suicide gene in gastrointestinal cancer therapy.

Clinical & Experimental Metastasis
Ye-Hyeon AhnKyung-Hee Chun

Abstract

Aberrant activation of Signal Transducer and Activator of Transcription 3 (STAT3) signaling has been shown to be associated with uncontrolled cell proliferation and suppression of host-immune surveillance. Conversely, silencing STAT3 can have the dual effects of inhibiting cancer cell proliferation and inducing anti-tumor immune responses. Here, we report on the effects of STAT3 silencing on suicide gene therapy with thymidine kinase (tk). STAT3 silencing by siRNA inhibited the proliferation of AGS human gastric cancer cells through G1 cell cycle arrest, decreased levels of immune-suppressive cytokines, and increased levels of immune-activating cytokines. CT26 mouse colon adenocarcinoma cells, in which STAT3 expression was knocked-down by a STAT3 shRNA-containing lentivirus, grew more slowly in syngenic model Balb/c mice than control CT26 cells. Moreover, we found that STAT3 silencing augmented the efficacy of suicide gene therapy in CT26 cell xenografted mice. When we administrated adenoviruses harboring the herpes simplex virus thymidine kinase gene (Ad5.CMV.HSV.tk) into STAT3-silenced CT26 cell tumors, extensive apoptosis was observed and there was a significant reduction in the size of CT26 cell tumors. STAT3 silencing also...Continue Reading

References

Oct 10, 1998·International Journal of Cancer. Journal International Du Cancer·S ZushiY Matsuzawa
Sep 1, 2005·Chemical Immunology and Allergy·Justine S FitzgeraldUdo R Markert
Dec 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wen-Chang LiHong Zhang
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Suyun Huang
May 2, 2007·Journal of Immunotherapy·Marcin Kortylewski, Hua Yu
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Noriyuki ItoOsamu Ogawa
Jul 7, 2007·Expert Opinion on Therapeutic Targets·Hongwei Gao, Peter A Ward
Dec 7, 2007·Cancer Biology & Therapy·Chi Keung LauSheung Tat Fan
Mar 25, 2008·International Journal of Cancer. Journal International Du Cancer·James E LittlejohnW Roy Smythe
May 16, 2008·Current Opinion in Immunology·Marcin Kortylewski, Hua Yu
May 29, 2008·Molecular Cancer Research : MCR·Emily C Brantley, Etty N Benveniste
Jul 31, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Takayuki SuzukiHiroyuki Mizuguchi
Jan 20, 2009·Neoplasma·D S AriciA Koyuncu
Apr 17, 2009·Journal of Gastroenterology and Hepatology·Cameron B Jackson, Andrew S Giraud
Oct 13, 2009·Gastroenterology·Seok-Jun KimKyung-Hee Chun
Jul 5, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Seok-Jun KimKyung-Hee Chun
Oct 1, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Takayuki SuzukiHiroyuki Mizuguchi

❮ Previous
Next ❯

Citations

Jul 3, 2015·Clinical & Experimental Metastasis·Hyun-Woo LeeKyung-Hee Chun
Jul 1, 2016·Oncotarget·Hye-Young KimKyung-Hee Chun
Feb 19, 2015·The Journal of Biological Chemistry·Seung-Won ChoiKyung-Hee Chun
Apr 10, 2021·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Seok-Jun KimKyung-Hee Chun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.